Inward FDI in Germany and its policy context
With a stable economic and political system, open capital markets, the largest domestic market in Europe, and European Union (EU) membership, Germany has attracted competitive and export-oriented multinational enterprises (MNEs) since the 1960s. In the 1990s —after German unification and the opening up of Eastern Europe— inward foreign direct investment (IFDI) grew more slowly than expected despite the increased market potential. In recent years, the German economy strengthened and the wage and cost gaps against its main competitors narrowed, contributing to higher IFDI. With the financial and economic crises, German IFDI declined considerably in 2008 but started to rise again in 2009. At the end of 2008, Germany ranked among the top four developed countries as host for IFDI. Germany's open investment regime was tightened in 2009, in reaction to the emergence of sovereign wealth funds (SWFs). Trends and developments Country-level developments The successful reintegration of Germany into the world economy after the Second World War, as well as the European unification process, stimulated IFDI in Germany. Already in the 1960s, many of the largest MNEs worldwide (like General Motors or IBM) had established affiliates in Germany. In 1990, the year of the German reunification, the consolidated primary and secondary IFDI stock amounted to US$ 111 billion. 1 Since then, it has risen six-fold, to reach US$ 666 * Thomas Jost (thomas.jost@h-ab.de) is Professor of Economics at the University of Applied Sciences Aschaffenburg. The author wishes to thank Alexandra Angress, Jörn Kleinert and Beatrix Stejskal-Passler for their helpful comments. The views expressed by the author of this Profile do not necessarily reflect opinions of Columbia University, its partners and supporters. Columbia FDI Profiles is a peer-reviewed series. 1 The German inward FDI stock figures that are used most for analysis in this article are consolidated primary and secondary direct investment stock figures. This is a very special calculation done by Deutsche Bundesbank, looking through dependent (majority foreign owned) holding companies in Germany and including their direct investment enterprises in Germany. These figures are not comparable with the figures of most other countries, taking only primary FDI into account. The primary FDI stock in Germany is much higher than the consolidated primary and secondary one, because FDI in dependent holding companies is much higher than the FDI stock in their direct investment enterprises, which replace the dependent holding companies by consolidation. The reason for this is that the holding companies receive …
Overseas State Outsiders as New Sources of Patient Capital: Government Policies to Welcome Sovereign Wealth Fund Investment in France and Germany
The strong debates in the varieties of capitalism literature as to whether financial liberalisation and internationalisation undermine ‘insider’ corporate governance systems based on patient capital in coordinated and state-led market economies have focused on ‘impatient’ overseas private capital. However, cross-border state investment has also grown. We examine government policies towards a different type of overseas investment- state equity purchases by Sovereign Wealth Funds. We argue that policy makers in insider’ corporate governance systems can see such investment as an attractive international source of patient capital that can offset declines in traditional sources of patient capital. We compare two polities -- Germany and France -- and show that policy makers actively welcome and seek SWF investment, driven by coalitions of ‘insiders’ composed of the managements of large industrial firms and governments who seek passive patient capital and beneficial relationships with overseas investors. Thus, overseas state investors can provide new sources of patient capital.
Key Considerations for an Economic and Legal Framework Facilitating Medical Travel
Medical travel has the capacity to counter increasing costs of health care by creating new markets and increased revenue for health services, potentially benefiting local populations, economies, and health-care systems. This paper is part of a broad, comprehensive project aimed at developing a global health access policy (GHAP). It presents key issues to consider in terms of ensuring economic viability, sustainability, and limiting risk to the many stakeholders involved in the rapidly expanding industry of medical travel. The noted economic and legal barriers to medical travel are based on a synthesis of themes found in an extensive review of the available literature. Economic considerations, when setting up a GHAP, include a dynamic approach to pricing that is fair to the local population. Legal considerations include the implementation of international quality standards and the protection of the rights of those traveling as well as those of local populations in recipient countries. By taking into account these opportunities, the GHAP will more adequately address existing gaps in the economic and legal regulation of medical travel.